|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01612 VINCENT MED
Nominal 
0.830 -0.030 (-3.488%) | 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Turnover | 800,963 | 11.559% | 717,973 | 629,242 | 777,720 | 1,155,383 |
| Cost of Sales | (540,971) | 13.272% | (477,586) | (463,889) | (518,616) | (661,146) |
| Gross Profit | 259,992 | 8.156% | 240,387 | 165,353 | 259,104 | 494,237 |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (328) | -- | 2,817 | (1,664) | (5,879) | (4,753) | |
| Profit / (Loss) before Taxation | 77,979 | 16.534% | 66,915 | (15,516) | 66,180 | 284,084 | |
| Taxation | (7,083) | -18.652% | (8,707) | (2,874) | (6,110) | (36,649) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (1,729) | 85.316% | (933) | 992 | 625 | (30,570) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 69,167 | 20.763% | 57,275 | (17,398) | 60,695 | 216,865 | |
| 2024/12 - Final HKD(K$) | %Chg (Compare to Final) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | |
| Net Finance Costs / (Income) | 159 | -83.858% | 985 | 2,342 | 2,046 | 3,167 |
| Depreciation & Amortisation | 36,568 | -4.599% | 38,331 | 40,952 | 40,063 | 37,016 |
| Directors' Emoluments | 7,058 | 2.946% | 6,856 | 7,245 | 6,912 | 11,081 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | |
| EPS (cts) | 10.750 | 21.195% | 8.870 | -2.660 | 9.280 | 33.840 |
| DPS (cts) | 3.300 | -- | 2.750 | 2.500 | 4.500 | 11.000 |
| Dividend Payout Ratio (%) | 30.698% | -- | 31.003% | -- | 48.491% | 32.506% |
| Cash flow per share ($) | 0.114 | -- | 0.194 | 0.116 | 0.182 | 0.325 |
| NBV per share ($) | 0.886 | -- | 0.829 | 0.762 | 0.914 | 0.940 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 51,629 |
| %Change | 55.098% |
| EPS / (LPS) | HKD 0.080 |
| NBV Per Share ($) | HKD 0.954 |